株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の動物用ワクチン市場の分析と予測:製品(生ワクチン、不活化ワクチン、サブユニットワクチン、DNAワクチン、組換えワクチン)、動物タイプ(愛玩動物、ウシ、ブタ、家禽、ウマ)、地域別

Veterinary/Animal Vaccines Market Analysis By Product (Attenuated Live, Inactivated, Subunit, DNA and Recombinant), By Animal Type (Companion Animal, Cattle, Poultry, Equine), And Segment Forecasts, 2014 - 2025

発行 Grand View Research, Inc. 商品コード 600775
出版日 ページ情報 英文 100 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.69円で換算しております。
Back to Top
世界の動物用ワクチン市場の分析と予測:製品(生ワクチン、不活化ワクチン、サブユニットワクチン、DNAワクチン、組換えワクチン)、動物タイプ(愛玩動物、ウシ、ブタ、家禽、ウマ)、地域別 Veterinary/Animal Vaccines Market Analysis By Product (Attenuated Live, Inactivated, Subunit, DNA and Recombinant), By Animal Type (Companion Animal, Cattle, Poultry, Equine), And Segment Forecasts, 2014 - 2025
出版日: 2017年12月04日 ページ情報: 英文 100 Pages
概要

世界の動物用ワクチン市場は2025年までに126億米ドルに達すると予測されています。家畜疾病の発生率の上昇、畜産の拡大、人獣共通感染症の増加、ペット所有者の増加、動物の健康に対する意識の向上などが、当市場の成長を促進しています。市販のワクチンに対する関心が高まっており、世界中で動物用ワクチンの導入が進んでいます。また、流通における政府の介入は、動物用ワクチン製造業者の収益性に影響を与えています。インドやアラスカなどの畜産農家の多い国では、家畜用ワクチンがバルク購入されており、利益率の低下をもたらしています。

当レポートでは、世界の動物用ワクチン市場について調査し、市場の概要、製品・動物タイプ・地域別の市場動向、市場規模の推移と予測、市場成長要因の分析、市場シェア、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査方法

  • 情報調達
  • データ分析
  • 市場予測のためのアプローチ

第2章 エグゼクティブサマリー

  • 市場のスナップショット

第3章 動物用ワクチン市場

  • 市場区分と範囲
  • 市場の成長要因分析
  • 市場の阻害要因分析
  • 普及と成長見通しマッピング
  • SWOT分析
  • 産業分析 - ファイブフォース分析
  • バリューチェーン分析

第4章 動物用ワクチン市場の動向と予測:製品別

  • 市場動向の分析:製品別
  • 生ワクチン
  • 不活化ワクチン
  • サブユニットワクチン
  • DNAワクチン
    • 組換えワクチン

第5章 動物用ワクチン市場の動向と予測:動物タイプ別

  • 市場動向の分析:動物タイプ別
  • 愛玩動物用ワクチン市場:疾病別
    • イヌ用ワクチン:疾病別
      • イヌジステンパー
      • ケンネル咳(パラインフルエンザ)
      • パルボウイルス
      • イヌヘルペス
      • ライム病
    • ネコ用ワクチン:疾病別
      • ネコカルシウイルス
      • ネコ伝染性腹膜炎(FIP)
      • ネコ免疫不全ウイルス(FIV)
  • ウシ用ワクチン:疾病別
    • 牛呼吸器合胞体ウイルス(BRSV)
    • 気管支肺炎
    • 牛伝染性鼻気管炎(IBR)
    • 牛ウイルス性下痢(BVD)
  • 家禽用ワクチン:疾病別
    • 家禽の感染性気管支炎
    • 鳥インフルエンザ
    • ニューカッスル病
    • マレック病
  • ブタ用ワクチン:疾病別
    • 豚繁殖・呼吸障害症候群(PRRS)
    • 豚インフルエンザ
    • 豚肺炎
  • ウマ用ワクチン:疾病別
    • 脳脊髄炎
    • 鼻炎
    • 馬インフルエンザ

第6章 動物用ワクチン市場の動向と分析:地域別

  • 動物用ワクチン市場:地域別
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合情勢

  • 企業プロファイル
目次
Product Code: GVR-2-68038-053-8

The global veterinary vaccines market is expected to reach USD 12.6 billion by 2025, according to a new report by Grand View Research, Inc. Rise in the outbreak of livestock diseases, expanding livestock population and increasing zoonotic diseases are driving the market growth. Increasing awareness regarding commercially available vaccines is pushing the adoption globally. However, higher costs associated with storage is challenging the growth and restricting the entry of new players.

This market has emerged to be one of the profitable investment options seeking attention and investments from both government and non-government players. Rise in the number of pet owners and their shifting focus towards healthy animal practices are some other factors propelling the growth of the market. Government intervention in distribution channel on the other hand, is affecting the profitability of the veterinary vaccine manufacturers. The bulk purchase and supply of livestock vaccines by countries such as India and Alaska that have large livestock population are reducing the profit margins of the vaccine manufacturers' through bulk pricing.

Further Key Findings from the Report Suggest:

  • Attenuated vaccines emerged as the largest segment as a result of the benefits such as improved effectivity and enhanced long-term prevention
  • Cattle vaccines accounted for the largest share in the animal type segment owing to the rise in the demand for safe animal products
  • Companion animal vaccines segment is the fastest growing segment owing to the increase in number of pet owners worldwide
  • North America dominated the market with the largest share in 2016. Constantly rising awareness regarding animal health and increasing commercialization of animal products are facilitating dominance of the region during the forecast period.
  • Asia Pacific is projected to witness swift growth during the forecast period owing to the speedy adoption of veterinary vaccines for quality food products and better animal health
  • Key players including Zoetis, Virbac Inc. Indian Immunological Limited, Heska Corp., Boehringer Inghlem, Bayer Pharma Ag, Merck Animal Health and Biogenesis Bago dominated the global veterinary vaccines market.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Information procurement
  • 1.2 Data Analysis
  • 1.3 Approaches for market estimation
    • 1.3.1 Approach 1: Demand Analysis & Bottom up Approach
    • 1.3.2 Approach 2: Top down market estimation
    • 1.3.3 Approach 3: Commodity flow and bottom up market estimation
    • 1.3.4 Approach 4: KoL perspective based market sizing

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Veterinary Vaccines Market Variables, Trends & Scope

  • 3.1 Market segmentation & scope
  • 3.2 Market Driver Analysis
  • 3.3 Market Restraint Analysis
  • 3.4 Penetration & growth prospect mapping
  • 3.5 Veterinary Vaccines Market - SWOT Analysis, By Factor (political & legal, economic and technological)
  • 3.6 Industry Analysis - Porter's
  • 3.7 Value Chain Analysis

Chapter 4 Veterinary Vaccines Market: Product Estimates & Trend Analysis

  • 4.1 Veterinary vaccines market: Product type movement analysis
  • 4.2 Attenuated Live Vaccines
    • 4.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
  • 4.3 Inactivated Vaccines
    • 4.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)
  • 4.4 Subunit vaccines
    • 4.4.1 Market estimates and forecast, 2014 - 2025 (USD Million)
  • 4.5 DNA vaccines
    • 4.5.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 4.5.2 Recombinant vaccines
      • 4.5.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)

Chapter 5 Veterinary Vaccines Market: By Animal Type Estimates & Trend Analysis

  • 5.1 Veterinary Vaccines Market: Animal type movement analysis
  • 5.2 Companion animal vaccines, by disease type
      • 5.2.1.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.2.2 Canine
      • 5.2.2.1 Market estimates and forecast, 2014 - 2025(USD Million)
    • 5.2.3 Canine Distemper
      • 5.2.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.2.4 Kennel cough (Parainfluenza)
      • 5.2.4.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.2.5 Parvovirus
      • 5.2.5.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.2.6 Canine Herpes
      • 5.2.6.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.2.7 Lyme Disease
      • 5.2.7.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.2.8 Feline
      • 5.2.8.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.2.9 Feline calcivirus
      • 5.2.9.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.2.10 Feline Infectious Peritonitis (FIP)
      • 5.2.10.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.2.11 Feline Immunodeficiency Virus (FIV)
      • 5.2.11.1 Market estimates and forecast, 2014 - 2025 (USD Million)
  • 5.3 Cattle vaccines, by disease type
    • 5.3.1 Bovine Respiratory Syncytial Virus (BRSV)
      • 5.3.1.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.3.2 Enzootic Bronchopneu
      • 5.3.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.3.3 Infectious Bovine Rhinotracheitis (IBR)
      • 5.3.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.3.4 Bovine Viral Diarrhea (BVD)
      • 5.3.4.1 Market estimates and forecast, 2014 - 2025 (USD Million)
  • 5.4 Poultry vaccines, by disease type
    • 5.4.1 Infectious Bronchitis in Poultry
      • 5.4.1.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.4.2 Avian Influenza
      • 5.4.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.4.3 Newcastle disease
      • 5.4.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.4.4 Marek's disease
      • 5.4.4.1 Market estimates and forecast, 2014 - 2025 (USD Million)
  • 5.5 Pig vaccines, by disease
    • 5.5.1 Porcine reproductive and respiratory syndrome
      • 5.5.1.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.5.2 Swine influenza
      • 5.5.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.5.3 Swine pneumonia
      • 5.5.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)
  • 5.6 Equine vaccines, by disease
    • 5.6.1 Encephalomyelitis
      • 5.6.1.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.6.2 Rhino pneumonitis
      • 5.6.2.1 Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.6.3 Horse flu (Influenza)
      • 5.6.3.1 Market estimates and forecast, 2014 - 2025 (USD Million)

Chapter 6 Veterinary Vaccines Market: Regional Estimates & Trend Analysis, by Product and Animal Type

  • 6.1 Veterinary vaccines market: Regional movement analysis
  • 6.2 North America
    • 6.2.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
    • 6.2.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
    • 6.2.3 U.S.
      • 6.2.3.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
      • 6.2.3.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
    • 6.2.4 Canada
      • 6.2.4.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
      • 6.2.4.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
  • 6.3 Europe
    • 6.3.1. Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
    • 6.3.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
    • 6.3.3 U.K.
      • 6.3.3.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
      • 6.3.3.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
    • 6.3.4 Germany
      • 6.3.4.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
      • 6.3.4.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
    • 6.4.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
    • 6.4.2 India
      • 6.4.2.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
      • 6.4.2.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
    • 6.4.3 China
      • 6.4.3.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
      • 6.4.3.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
    • 6.5.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
      • 6.5.2.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
      • 6.5.3.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
  • 6.6 Middle East and Africa (MEA)
    • 6.6.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
    • 6.6.1 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 Market Estimates and Forecast, by Product Type, 2014 - 2025 (USD Million)
      • 6.6.2.2 Market Estimates and Forecast, by Animal Type, 2014 - 2025 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Company Profiles
    • 7.1.1 Merck & Co., Inc.
      • 7.1.1.1 Company overview
      • 7.1.1.2 Financial Performance
      • 7.1.1.3 Product benchmarking
      • 7.1.1.4 Strategic initiatives
    • 7.1.2 Zoetis
      • 7.1.2.1 Company Overview
      • 7.1.2.2 Financial Performance
      • 7.1.2.3 Product Benchmarking
      • 7.1.2.4 Strategic Overview
    • 7.1.3 Boehringer Ingelheim
      • 7.1.3.1 Company Overview
      • 7.1.3.2 Financial Performance
      • 7.1.3.3 Product Benchmarking
      • 7.1.3.4 Strategic Initiatives
    • 7.1.4 Bayer AG
      • 7.1.4.1 Company Overview
      • 7.1.4.2 Financial Performance
      • 7.1.4.3 Product Benchmarking
      • 7.1.4.4 Strategic Initiatives
    • 7.1.5 Virbac Inc.
      • 7.1.5.1 Company Overview
      • 7.1.5.2 Financial Performance
      • 7.1.5.3 Product Benchmarking
      • 7.1.5.4 Strategic Initiatives
    • 7.1.6 Biogenesis Bago S.A.
      • 7.1.6.1 Company Overview
      • 7.1.6.2 Financial Performance
      • 7.1.6.3 Product Benchmarking
      • 7.1.6.4 Strategic Initiatives
    • 7.1.7 Indian Immunological Limited
      • 7.1.7.1 Company Overview
      • 7.1.7.2 Financial Performance
      • 7.1.7.3 Product Benchmarking
      • 7.1.7.4 Strategic Initiatives
    • 7.1.8 Heska Corporation
      • 7.1.8.1 Company Overview
      • 7.1.8.2 Financial Performance
      • 7.1.8.3 Product Benchmarking
      • 7.1.8.4 Strategic Initiatives

List of Tables

  • TABLE 1 North America veterinary vaccines market, by product, 2014 - 2025 (USD Million)
  • TABLE 2 North America veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
  • TABLE 3 U.S. veterinary vaccines market, by product, 2014 - 2025 (USD Million)
  • TABLE 4 U.S. veterinary vaccines market, by animal type, 2014 - 2025 (USD million)
  • TABLE 5 Canada veterinary vaccines market, by product, 2014 - 2025 (USD Million)
  • TABLE 6 Canada veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
  • TABLE 7 Europe veterinary vaccines market, by product, 2014 - 2025 (USD Million)
  • TABLE 8 Europe veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
  • TABLE 9 U.K. veterinary vaccines market, by product, 2014 - 2025 (USD Million)
  • TABLE 10 U.K. veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
  • TABLE 11 Germany veterinary vaccines market, by product, 2014 - 2025 (USD Million)
  • TABLE 12 Germany veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
  • TABLE 13 Asia Pacific veterinary vaccines market, by product, 2014 - 2025 (USD Million)
  • TABLE 14 Asia Pacific veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
  • TABLE 15 Japan veterinary vaccines market, by product, 2014 - 2025 (USD Million)
  • TABLE 16 Japan veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
  • TABLE 17 China veterinary vaccines market, by product, 2014 - 2025 (USD Million)
  • TABLE 18 China veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
  • TABLE 19 Latin America veterinary vaccines market, by product, 2014 - 2025 (USD Million)
  • TABLE 20 Latin America veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
  • TABLE 21 Brazil veterinary vaccines market, by product, 2014 - 2025 (USD Million)
  • TABLE 22 Brazil veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
  • TABLE 23 Mexico veterinary vaccines market, by product, 2014 - 2025 (USD Million)
  • TABLE 24 Mexico veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
  • TABLE 25 MEA veterinary vaccines market, by product, 2014 - 2025 (USD Million)
  • TABLE 26 MEA veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)
  • TABLE 27 South Africa veterinary vaccines market, by product, 2014 - 2025 (USD Million)
  • TABLE 28 South Africa veterinary vaccines market, by animal type, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market summary (USD Million)
  • FIG. 8 Value Chain Analysis : Veterinary Vaccines Market
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market segmentation & scope
  • FIG. 11 Market driver relevance analysis (Current & future impact)
  • FIG. 12 Market restraint relevance analysis (Current & future impact)
  • FIG. 13 Penetration & growth prospect mapping
  • FIG. 14 Penetration & growth prospect mapping
  • FIG. 15 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 16 Porter's Five Forces Analysis
  • FIG. 17 Veterinary vaccines market product outlook key takeaways
  • FIG. 18 Veterinary vaccines market: Product movement analysis
  • FIG. 19 Attenuated live vaccines market, 2014 - 2025 (USD Million)
  • FIG. 20 Inactivated vaccines market, 2014 - 2025 (USD Million)
  • FIG. 21 Subunit vaccines market, 2014- 2025 (USD Million)
  • FIG. 22 DNA vaccines market, 2014 - 2025 (USD Million)
  • FIG. 23 Recombinant vaccines market, 2014 - 2025 (USD Million)
  • FIG. 24 Veterinary vaccines market animal type outlook key takeaways
  • FIG. 25 Veterinary vaccines market: Animal type movement analysis
  • FIG. 26 Companion animal vaccines market, 2014 - 2025 (USD Million)
  • FIG. 27 Canine disease market, 2014 - 2025 (USD Million)
  • FIG. 28 Canine distemper market, 2014 - 2025 (USD Million)
  • FIG. 29 Kennel cough market, 2014 - 2025 (USD Million)
  • FIG. 30 Parvovirus market, 2014 - 2025 (USD Million)
  • FIG. 31 Canine herpes market, 2014 - 2025 (USD Million)
  • FIG. 32 Lyme disease market, 2014 - 2025 (USD Million)
  • FIG. 33 Feline vaccines market, 2014 - 2025 (USD Million)
  • FIG. 34 Feline calcivirus market, 2014 - 2025 (USD Million)
  • FIG. 35 Feline Infectious Peritonitis market, 2014 - 2025 (USD Million)
  • FIG. 36 Feline Immunodeficiency Virus market, 2014 - 2025 (USD Million)
  • FIG. 37 BRSV market, 2014 - 2025 (USD Million)
  • FIG. 38 Enzootic Bronchopneu market, 2014 - 2025 (USD Million)
  • FIG. 39 IBR market, 2014 - 2025 (USD Million)
  • FIG. 40 BVD market, 2014 - 2025 (USD Million)
  • FIG. 41 IBP market, 2014 - 2025 (USD Million)
  • FIG. 42 Avian influenza market, 2014 - 2025 (USD Million)
  • FIG. 43 Newcastle Disease market, 2014 - 2025 (USD Million)
  • FIG. 44 Marek's disease market, 2014 - 2025 (USD Million)
  • FIG. 45 PRRS market, 2014 - 2025 (USD Million)
  • FIG. 46 Swine influenza market, 2014 - 2025 (USD Million)
  • FIG. 47 Swine pneumonia market, 2014 - 2025 (USD Million)
  • FIG. 48 Encephalomyelitis market, 2014 - 2025 (USD Million)
  • FIG. 49 Rhino pneumonitis market, 2014 - 2025 (USD Million)
  • FIG. 50 Horse flu market, 2014 - 2025 (USD Million)
  • FIG. 51 Regional market place: Key takeaways
  • FIG. 52 Veterinary vaccines: regional movement analysis
  • FIG. 53 North America market, 2014 - 2025 (USD Million)
  • FIG. 54 U.S. market, 2014 - 2025 (USD Million)
  • FIG. 55 Canada market, 2014 - 2025 (USD Million)
  • FIG. 56 Europe market, 2014 - 2025 (USD Million)
  • FIG. 57 U.K. market, 2014 - 2025 (USD Million)
  • FIG. 58 Germany market, 2014 - 2025 (USD Million)
  • FIG. 59 Asia-Pacific market, 2014 - 2025 (USD Million)
  • FIG. 60 India market, 2014 - 2025 (USD Million)
  • FIG. 61 China market, 2014 - 2025 (USD Million)
  • FIG. 62 Latin America market, 2014 - 2025 (USD Million)
  • FIG. 63 Brazil market, 2014 - 2025 (USD Million)
  • FIG. 64 Mexico market, 2014 - 2025 (USD Million)
  • FIG. 65 MEA market, 2014 - 2025 (USD Million)
  • FIG. 66 South Africa market, 2014 - 2025 (USD Million)
  • FIG. 67 Strategy framework
Back to Top